148554-82-9 Usage
Description
(+/-)-α-<(methoxycarbonyl)amino>benzenebutanoic acid, also known as racemic ibuprofen, is a nonsteroidal anti-inflammatory drug (NSAID) that is commonly used to relieve pain, reduce fever, and alleviate inflammation. It has a chemical structure consisting of a benzene ring with a carboxylic acid and an isobutyl group attached to it, along with a methoxycarbonylamino functional group. This drug works by inhibiting the production of prostaglandins, which are hormone-like compounds that play a key role in the body's inflammatory response.
Uses
Used in Pharmaceutical Industry:
(+/-)-α-<(methoxycarbonyl)amino>benzenebutanoic acid is used as an analgesic for relieving pain, such as headaches and muscle aches. It is also used as an antipyretic to reduce fever and as an anti-inflammatory agent to alleviate inflammation.
Used in Treatment of Arthritis:
In the field of rheumatology, (+/-)-α-<(methoxycarbonyl)amino>benzenebutanoic acid is used as a treatment for various types of arthritis, including osteoarthritis and rheumatoid arthritis, to help manage pain and inflammation.
Used in Relief of Menstrual Cramps:
(+/-)-α-<(methoxycarbonyl)amino>benzenebutanoic acid is used as a medication to alleviate the pain and discomfort associated with menstrual cramps.
It is important to use (+/-)-α-<(methoxycarbonyl)amino>benzenebutanoic acid as directed, as it can cause side effects such as stomach irritation and an increased risk of heart attack or stroke, especially when used at high doses or for long periods of time.
Check Digit Verification of cas no
The CAS Registry Mumber 148554-82-9 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,8,5,5 and 4 respectively; the second part has 2 digits, 8 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 148554-82:
(8*1)+(7*4)+(6*8)+(5*5)+(4*5)+(3*4)+(2*8)+(1*2)=159
159 % 10 = 9
So 148554-82-9 is a valid CAS Registry Number.
148554-82-9Relevant articles and documents
ANTI-VIRAL COMPOUNDS
-
Paragraph 0373; 0374, (2015/11/24)
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
Anti-Viral Compounds
-
, (2010/11/03)
Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
An efficient synthesis of chiral homophenylalanine derivatives via enantioselective hydrogenation
Li, Xingshu,Yeung, Chi-Hung,Chan, Albert S. C.,Lee, Dong-Sheng,Yang, Teng-Kuei
, p. 3863 - 3867 (2007/10/03)
Chiral homophenylalanine derivatives were synthesized via enantioselective hydrogenation of 5a and 5b catalyzed by rhodium complexes bearing chiral phosphine and phosphinite legands. Enantiomeric excesses up to 96.2% were achieved when S-spiroOP(S-1) was used as a chiral ligand under 500 psi of H2 pressure in acetone.
